Document Classification

Section Type: RESULTS

Text: Whereas no change was observed in the placebo group after treatment, patients receiving pioglitazone showed a significant increase in whole body glucose disposal (3. 93 + / - 1. 59 mg/kg/min to 5. 24 + / - 1. 65 mg/kg/min ; p = 0. 004) and MGU (0. 62 + / - 0. 26 micromol/g/min to 0. 81 + / - 0. 14 micromol/g/min ; p = 0. 0007), accompanied by a significant improvement in resting MBF (1. 11 + / - 0. 20 ml/min/g to 1. 25 + / - 0. 21 ml/min/g ; p = 0. 008).